Home Cart 0 Sign in  
X

[ CAS No. 84905-80-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 84905-80-6
Chemical Structure| 84905-80-6
Chemical Structure| 84905-80-6
Structure of 84905-80-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 84905-80-6 ]

Related Doc. of [ 84905-80-6 ]

Alternatived Products of [ 84905-80-6 ]

Product Details of [ 84905-80-6 ]

CAS No. :84905-80-6 MDL No. :MFCD06658411
Formula : C6H4ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :ZGJDDWOXVGDTSP-UHFFFAOYSA-N
M.W : 153.57 Pubchem ID :5370695
Synonyms :

Calculated chemistry of [ 84905-80-6 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.9
TPSA : 41.57 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.4
Log Po/w (XLOGP3) : 1.38
Log Po/w (WLOGP) : 1.61
Log Po/w (MLOGP) : 0.37
Log Po/w (SILICOS-IT) : 2.24
Consensus Log Po/w : 1.4

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.33
Solubility : 0.722 mg/ml ; 0.0047 mol/l
Class : Soluble
Log S (Ali) : -1.86
Solubility : 2.14 mg/ml ; 0.0139 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.14
Solubility : 0.112 mg/ml ; 0.000728 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 84905-80-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 84905-80-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 84905-80-6 ]
  • Downstream synthetic route of [ 84905-80-6 ]

[ 84905-80-6 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 5655-01-6 ]
  • [ 84905-80-6 ]
YieldReaction ConditionsOperation in experiment
89% for 1 h; Inert atmosphere; Reflux Step 4: Preparation of 4-Chloropyrrolo[3,2-d]Pyrimidine (32e) To a sample of 3H,5H-Pyrrolo[3,2-d]pyrimidin-4-one (32d) (31.08 g, 230 mmol) under N2 was added phosphorus oxy chloride (60 mL, 644 mol). The mixture was heated at reflux for 1 h during which time the reaction became black homogenous. The reaction was cooled in an ice-water bath and then poured into chipped ice (775 mL) with stirring. The pH of the aqueous solution was slowly adjusted to ~ pH 8 with concentrated NH4OH (225 mL) with continued cooling of the mixture. The resulting precipitate was collected by vacuum filtration and washed with water. The solid was transferred to a drying tray and dried in vacuum at 110 °C to furnish 4-Chloropyrrolo[3,2-d]Pyrimidine (32e) (31.48 g, 89percent) as a dark gray solid. An analytical sample was obtained by column chromatography (Silica gel, EtOAc-hexanes, 35:65) followed by evaporation of the relevant fractions. Trituration of the solid with EtOAc-MeOH afforded 4-Chloropyrrolo[3,2-d]Pyrimidine (32e) as an off-white solid, MP >150 °C (dec); 1H NMR (DMSO-< 5) δ 12.43 (s, D20 exchangeable, 1H), 8.61 (s, 1H), 7.97 (dd, J = 2.8, 2.8 Hz; D20 exchange collapse to d, 1H), 6.72 (dd, J = 1.7, 3.5 Hz; D20 exchange collapse to d, 1H). 13C-NMR (DMSO-d6) 151.30, 149.58, 142.12, 134.83, 124.32, 102.70; IR (neat) 3128, 3078, 2979, 1621 cm"1; MS (ES+) 154.01 (100percent, M+l) and 156.01 (33percent); Analysis calculated for C6H4N3C1: C, 46.93; H, 2.63; N, 27.36; CI, 23.09; Found: C, 47.10; H, 2.79; N, 27.15; CI, 22.93.
57%
Stage #1: for 2 h; Heating / reflux
Stage #2: With potassium carbonate In water at 20℃;
A mixture of 3,5-dihydropyrrolo[3,2-
36%
Stage #1: for 1 h; Reflux
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Step 4: Into a 50-mL round-bottom flask was placed a solution of 3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one (5 g, 35.52 mmol, 1.00 equiv, 96percent) in trichlorophosphate (20 mL). The resulting solution was stirred at reflux for 1 h, concentrated under vacuum, dissolved in 100 mL of ethyl acetate, washed with 2.x.100 mL of 10percent aqueous sodium bicarbonate and 1.x.100 mL of brine, dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column eluted with ethyl acetate/petroleum ether (1:8) to afford 2 g (36percent) of 4-chloro-5H-pyrrolo[3,2-d]pyrimidine as a yellow solid.
Reference: [1] Organic Process Research and Development, 2009, vol. 13, # 5, p. 928 - 932
[2] Patent: WO2014/78778, 2014, A2, . Location in patent: Page/Page column 105
[3] Journal of Organic Chemistry, 2011, vol. 76, # 21, p. 8658 - 8669
[4] Patent: WO2008/70507, 2008, A2, . Location in patent: Page/Page column 150-151
[5] Patent: US2012/202785, 2012, A1, . Location in patent: Page/Page column 129
[6] Journal of Medicinal Chemistry, 2009, vol. 52, # 19, p. 5974 - 5989
[7] Journal of Organic Chemistry, 2001, vol. 66, # 17, p. 5723 - 5730
[8] Journal of Organic Chemistry, 2001, vol. 66, # 17, p. 5723 - 5730
[9] Patent: WO2012/93809, 2012, A2, . Location in patent: Page/Page column 29
[10] Patent: US2013/274268, 2013, A1, . Location in patent: Paragraph 0206-0208
[11] Patent: EP2738174, 2014, A2, . Location in patent: Paragraph 0045; 0048; 0049
[12] Patent: US2014/163226, 2014, A1, . Location in patent: Paragraph 0131-0133
[13] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 14, p. 3199 - 3203
[14] Patent: WO2016/187183, 2016, A1, . Location in patent: Paragraph 0062
  • 2
  • [ 779326-74-8 ]
  • [ 84905-80-6 ]
Reference: [1] Patent: WO2012/93809, 2012, A2,
[2] Patent: US2013/274268, 2013, A1,
[3] Patent: WO2014/78778, 2014, A2,
[4] Patent: EP2738174, 2014, A2,
[5] Patent: US2014/163226, 2014, A1,
  • 3
  • [ 252932-48-2 ]
  • [ 84905-80-6 ]
Reference: [1] Patent: US2012/202785, 2012, A1,
[2] Patent: WO2016/187183, 2016, A1,
  • 4
  • [ 1021175-71-2 ]
  • [ 84905-80-6 ]
Reference: [1] Patent: US2012/202785, 2012, A1,
  • 5
  • [ 180059-04-5 ]
  • [ 84905-80-6 ]
Reference: [1] Patent: WO2014/78778, 2014, A2,
  • 6
  • [ 84905-80-6 ]
  • [ 2227-98-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 14, p. 6752 - 6763
[2] Journal of Organic Chemistry, 2011, vol. 76, # 21, p. 8658 - 8669
[3] Journal of Medicinal Chemistry, 2009, vol. 52, # 19, p. 5974 - 5989
[4] Patent: WO2016/187183, 2016, A1, . Location in patent: Paragraph 0062
  • 7
  • [ 84905-80-6 ]
  • [ 1032650-41-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 20, p. 7274 - 7282
[2] Patent: WO2012/93809, 2012, A2, . Location in patent: Page/Page column 29-30
[3] Patent: US2013/274268, 2013, A1, . Location in patent: Paragraph 0209-0211
[4] Patent: EP2738174, 2014, A2, . Location in patent: Paragraph 0045; 0050; 0051
[5] Patent: US2014/163226, 2014, A1, . Location in patent: Paragraph 0134-0136
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 84905-80-6 ]

Forodesine Intermediates

Chemical Structure| 252932-48-2

[ 252932-48-2 ]

Ethyl 3-amino-1H-pyrrole-2-carboxylate

Related Functional Groups of
[ 84905-80-6 ]

Chlorides

Chemical Structure| 943736-58-1

[ 943736-58-1 ]

4-Chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine

Similarity: 0.90

Chemical Structure| 89182-18-3

[ 89182-18-3 ]

4-Chloro-6-methylpyrimidin-5-amine

Similarity: 0.81

Chemical Structure| 2770-01-6

[ 2770-01-6 ]

4-Chloro-1H-imidazo[4,5-c]pyridine

Similarity: 0.74

Chemical Structure| 136927-64-5

[ 136927-64-5 ]

1-Chloropyrrolo[1,2-a]pyrazine

Similarity: 0.74

Chemical Structure| 1119280-66-8

[ 1119280-66-8 ]

2-Chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.73

Related Parent Nucleus of
[ 84905-80-6 ]

Other Aromatic Heterocycles

Chemical Structure| 943736-58-1

[ 943736-58-1 ]

4-Chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine

Similarity: 0.90

Chemical Structure| 272-50-4

[ 272-50-4 ]

5H-Pyrrolo[3,2-d]pyrimidine

Similarity: 0.79

Chemical Structure| 2770-01-6

[ 2770-01-6 ]

4-Chloro-1H-imidazo[4,5-c]pyridine

Similarity: 0.74

Chemical Structure| 136927-64-5

[ 136927-64-5 ]

1-Chloropyrrolo[1,2-a]pyrazine

Similarity: 0.74

Chemical Structure| 1119280-66-8

[ 1119280-66-8 ]

2-Chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.73